Schonfeld Strategic Advisors LLC Red Hill Biopharma Ltd. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.98 - $11.29 $161,936 - $261,927	-23,200 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$7.81 - $10.39 $1.03 Million - $1.37 Million	-132,200 Reduced 85.07%	23,200 $187,000
Q3 2020 Nov 16, 2020	BUY	$6.34 - $10.83 $350,602 - $598,899	55,300 Added 55.24%	155,400 $2,000
Q2 2020 Aug 14, 2020	SELL	$4.6 - $8.6 $114,539 - $214,140	-24,900 Reduced 19.92%	100,100 $671,000
Q1 2020 May 15, 2020	BUY	$3.51 - $6.17 $378,729 - $665,743	107,900 Added 630.99%	125,000 $566,000
Q4 2019 Feb 14, 2020	BUY	$5.76 - $7.35 $98,496 - $125,685	17,100 New	17,100 $104,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.